202 related articles for article (PubMed ID: 19529761)
1. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
Ray KJ; Lietman TM; Porco TC; Keenan JD; Bailey RL; Solomon AW; Burton MJ; Harding-Esch E; Holland MJ; Mabey D
PLoS Negl Trop Dis; 2009 Jun; 3(6):e458. PubMed ID: 19529761
[TBL] [Abstract][Full Text] [Related]
2. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
[TBL] [Abstract][Full Text] [Related]
3. Targeting antibiotics to households for trachoma control.
Blake IM; Burton MJ; Solomon AW; West SK; Basáñez MG; Gambhir M; Bailey RL; Mabey DC; Grassly NC
PLoS Negl Trop Dis; 2010 Nov; 4(11):e862. PubMed ID: 21072225
[TBL] [Abstract][Full Text] [Related]
4. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
5. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
[TBL] [Abstract][Full Text] [Related]
6. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
[TBL] [Abstract][Full Text] [Related]
7. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
[TBL] [Abstract][Full Text] [Related]
9. A rationale for continuing mass antibiotic distributions for trachoma.
Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
11. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
[TBL] [Abstract][Full Text] [Related]
13. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
Pickering H; Ramadhani AM; Massae P; Mafuru E; Malisa A; Mbuya K; Makupa W; Mtuy T; Derrick T; Houghton J; Bailey RL; Mabey DCW; Burton MJ; Holland MJ
Front Public Health; 2022; 10():1015714. PubMed ID: 36324475
[TBL] [Abstract][Full Text] [Related]
14. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
Gambhir M; Basáñez MG; Burton MJ; Solomon AW; Bailey RL; Holland MJ; Blake IM; Donnelly CA; Jabr I; Mabey DC; Grassly NC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e462. PubMed ID: 19529762
[TBL] [Abstract][Full Text] [Related]
15. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
[TBL] [Abstract][Full Text] [Related]
16. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
[TBL] [Abstract][Full Text] [Related]
17. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
Harding-Esch E; Jofre-Bonet M; Dhanjal JK; Burr S; Edwards T; Holland M; Sillah A; West S; Lietman T; Keenan J; Mabey D; Bailey R
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003670. PubMed ID: 25901349
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin in control of trachoma.
Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
[TBL] [Abstract][Full Text] [Related]
19. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
[TBL] [Abstract][Full Text] [Related]
20. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
